title: [Psychotherapy and pharmacotherapy for harmful tobacco use and tobacco dependency].
abstract: Tobacco consumption is one of the major preventable health risk factors. In Germany approximately 110,000 people prematurely die from tobacco-related diseases and approximately 50% of regular smokers are considered to be tobacco dependent. Nevertheless, motivation to quit smoking is low and the long-term abstinence rates after attempts to stop smoking without professional support are far below 10%. As part of the S3 treatment guidelines 78 recommendations for motivation and early interventions for smokers unwilling to quit as well as psychotherapeutic and pharmacological support for smokers willing to quit were formulated after an systematic search of the current literature. More than 50 professional associations adopted the recommendations and background information in a complex certification process. In this article the scientific evidence base regarding the psychotherapeutic and pharmacological treatment options as well as recommendations and further information about indications and treatment implementation are presented. By following these guidelines for treatment of heavy smokers who are willing to quit combined with individual and group therapies on the basis of behavioral treatment strategies and pharmacological support, long-term success rates of almost 30% can be achieved.
authors.affiliation: Sektion Suchtforschung und Suchttherapie, Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Tübingen, Calwer Str. 14, 72076, Tübingen, Deutschland. anil.batra@med.uni-tuebingen.de.
authors.forename: A
authors.initials: A
authors.lastname: Batra
authors.affiliation: Sektion Suchtforschung und Suchttherapie, Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Tübingen, Calwer Str. 14, 72076, Tübingen, Deutschland.
authors.forename: K U
authors.initials: KU
authors.lastname: Petersen
authors.affiliation: Klinik für Abhängiges Verhalten und Suchtmedizin, Zentralinstitut für Seelische Gesundheit, Mannheim, Deutschland.|Abt. Psychotherapie & Psychosomatik, Klinik und Poliklinik für Psychiatrie und Psychotherapie der LMU München, München, Deutschland.
authors.forename: E
authors.initials: E
authors.lastname: Hoch
authors.affiliation: Klinik für Abhängiges Verhalten und Suchtmedizin, Zentralinstitut für Seelische Gesundheit, Mannheim, Deutschland.
authors.forename: K
authors.initials: K
authors.lastname: Mann
authors.affiliation: Institut für Therapieforschung (IfT), München, Deutschland.
authors.forename: C
authors.initials: C
authors.lastname: Kröger
authors.affiliation: Milton-Erickson-Gesellschaft, Tübingen, Deutschland.
authors.forename: C
authors.initials: C
authors.lastname: Schweizer
authors.affiliation: Rhein-Jura-Klinik, Bad Säckingen, Deutschland.
authors.forename: A
authors.initials: A
authors.lastname: Jähne
authors.affiliation: Klinik für Psychiatrie und Psychotherapie, Klinikum der Universität München, München, Deutschland.
authors.forename: T
authors.initials: T
authors.lastname: Rüther
authors.affiliation: Psychiatrische und Psychotherapeutische Klinik, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Deutschland.
authors.forename: N
authors.initials: N
authors.lastname: Thürauf
authors.affiliation: Institut für Psychologie, Klinische Psychologie und Psychotherapie, Technische Universität Chemnitz, Chemnitz, Deutschland.
authors.forename: S
authors.initials: S
authors.lastname: Mühlig
mesh_terms: D019317:Evidence-Based Medicine; D005858:Germany; D019983:Guideline Adherence; D006801:Humans; D009462:Neurology / Q000592:standards; D017410:Practice Guidelines as Topic; D011570:Psychiatry / Q000592:standards*; D011613:Psychotherapy / Q000592:standards*; D020340:Tobacco Use Cessation / Q000379:methods* / Q000523:psychology; D061485:Tobacco Use Cessation Devices / Q000592:standards; D014029:Tobacco Use Disorder / Q000175:diagnosis / Q000523:psychology* / Q000628:therapy*; D016896:Treatment Outcome
keywords: Pharmacotherapy; Psychotherapy; Substance-related disorders; Tobacco use disorders; Treatment practice guidelines